Skip to main content
. Author manuscript; available in PMC: 2018 Feb 15.
Published in final edited form as: Int J Cancer. 2016 Nov 18;140(4):825–832. doi: 10.1002/ijc.30512

Table 2.

Associations between breast cancer susceptibility loci and measures of TDLU involution with statistically significant associations (P<0.05) among women in the Komen Tissue Bank and BREAST Stamp Project.

SNP Chr Locus TDLU counts
Acini count per TDLU
(TDLU counts)* (acini count per
TDLU)
RR* (95% CI)* P-trend* RR* (95% CI)* P-trend* RR* (95% CI)* P-trend*
rs616488 1 PEX14 1.16 (1.00,1.35) 0.047 1.08 (0.95,1.22) 0.239 1.07 (0.86,1.33) 0.550
rs1353747 5 PDE4D 1.00 (0.80,1.25) 0.981 1.28 (1.07,1.54) 0.007 1.40 (1.05,1.88) 0.024
rs11242675 6 FOXQ1 1.13 (1.00,1.28) 0.045 1.10 (0.98,1.23) 0.108 1.15 (0.97,1.37) 0.102
rs204247 6 RANBP9 0.93 (0.82,1.05) 0.259 0.92 (0.82,1.03) 0.144 0.81 (0.67,0.96) 0.017
rs6472903 8 8q21.11 1.06 (0.87,1.29) 0.563 1.18 (1.02,1.36) 0.027 1.08 (0.85,1.38) 0.515
rs6001930 22 MKL1 1.24 (1.02,1.50) 0.031 1.10 (0.92,1.33) 0.292 1.30 (0.99,1.72) 0.058

TDLU: Terminal duct lobular unit; SNP: Single nucleotide polymorphism; Chr: Chromosome; RR: Risk ratio; CI: Confidence interval.

*

Based on a multivariable Poisson regression model with robust variance adjusted for study and age (in categories: <30, 30-39, 40-49, 50-59, ≥60) and an offset variable accounting for the tissue area on the slide (in log scale). SNPs were modeled using additive coding for the number of breast cancer risk alleles (0, 1, 2).